Company Search:
Advanced Search
Sponsored Links
Cogstate Ltd Company Snapshot
Cogstate Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cogstate Ltd with three other companies in this sector in AUSTRALIA : Clinuvel Pharmaceuticals Limited (2020 sales of 33.13 million Australian Dollars [US$25.46 million] of which 100% was Biotechnology), Idt Australia Limited. (14.17 million Australian Dollars [US$10.89 million] ), and Mesoblast Ltd (47.97 million Australian Dollars [US$36.88 million] of which 100% was Adult Stem Cell Development).

Sales Analysis. During the second fiscal quarter of 2021, sales at Cogstate Ltd totalled A$19.00 million. This is an increase of 31.3% from the A$14.47 million in sales at the company during the second quarter of 2020. During the year ended June of 2020, sales at Cogstate Ltd were A$35.36 million (US$27.18 million). This is an increase of 15.6% versus 2019, when the company's sales were A$30.58 million. Despite this increase, sales are still below the level achieved in 2018, when Cogstate Ltd reported sales of A$37.49 million. Sales of Healthcare Market saw an increase that was more than double the company's growth rate: sales were up 745.8% in 2020, from A$414,691.60 to A$3.51 million. Cogstate Ltd also saw significant increases in sales in Research (up 50.0% to A$387,570.21 ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cogstate Ltd
  Stock Performance Chart for Cogstate Ltd
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 1.39
(Figures in Australian Dollars)
1 Week 50.3%   13 Weeks 65.5%  
4 Weeks 42.6%   52 Weeks 321.2%  
Cogstate Ltd Key Data:
  Ticker: CGS Country: Australia
  Exchanges: OTC BLN ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 35,356,885
(Year Ending Jan 2021).
Employees: 61
  Currency: Australian Dollars Market Cap: 236,631,280
  Fiscal Yr Ends: June Shares Outstanding: 170,238,331
  Share Type: Ordinary Closely Held Shares: 92,804,345
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.